Skip to main content
Top
Published in: Journal of General Internal Medicine 6/2011

01-06-2011 | Original Research

Financial Incentives for Extended Weight Loss: A Randomized, Controlled Trial

Authors: Leslie K. John, MS, George Loewenstein, PhD, Andrea B. Troxel, ScD, Laurie Norton, MA, Jennifer E. Fassbender, MS, Kevin G. Volpp, MD, PhD

Published in: Journal of General Internal Medicine | Issue 6/2011

Login to get access

ABSTRACT

BACKGROUND

Previous efforts to use incentives for weight loss have resulted in substantial weight regain after 16 weeks.

OBJECTIVE

To evaluate a longer term weight loss intervention using financial incentives.

DESIGN

A 32-week, three-arm randomized controlled trial of financial incentives for weight loss consisting of a 24-week weight loss phase during which all participants were given a weight loss goal of 1 pound per week, followed by an 8-week maintenance phase.

PARTICIPANTS

Veterans who were patients at the Philadelphia Veterans Affairs Medical Center with BMIs of 30–40.

INTERVENTION

Participants were randomly assigned to participate in either a weight-monitoring program involving a consultation with a dietician and monthly weigh-ins (control condition), or the same program with one of two financial incentive plans. Both incentive arms used deposit contracts (DC) in which participants put their own money at risk (matched 1:1), which they lost if they failed to lose weight. In one incentive arm participants were told that the period after 24 weeks was for weight-loss maintenance; in the other, no such distinction was made.

MAIN MEASURE

Weight loss after 32 weeks.

KEY RESULTS

Results were analyzed using intention-to-treat. There was no difference in weight loss between the incentive arms (P = 0.80). Incentive participants lost more weight than control participants [mean DC = 8.70 pounds, mean control = 1.17, P = 0.04, 95% CI of the difference in means (0.56, 14.50)]. Follow-up data 36 weeks after the 32-week intervention had ended indicated weight regain; the net weight loss between the incentive and control groups was no longer significant (mean DC = 1.2 pounds, 95% CI, -2.58–5.00; mean control = 0.27, 95% CI, -3.77–4.30, P = 0.76).

CONCLUSIONS

Financial incentives produced significant weight loss over an 8-month intervention; however, participants regained weight post-intervention.
Literature
1.
go back to reference Ogden C, Carroll M, Curtin L, McDowell M, Tabak C, Flegal K. Prevalence of overweight and obesity in the United States. J Am Med Assoc. 2006;393(15):1549–55.CrossRef Ogden C, Carroll M, Curtin L, McDowell M, Tabak C, Flegal K. Prevalence of overweight and obesity in the United States. J Am Med Assoc. 2006;393(15):1549–55.CrossRef
2.
go back to reference Jeffery RW, Thompson PD, Wing RR. Effects on weight reduction of strong monetary contracts for calorie restriction or weight loss. Behav Res Ther. 1978;16(5):363–9.PubMedCrossRef Jeffery RW, Thompson PD, Wing RR. Effects on weight reduction of strong monetary contracts for calorie restriction or weight loss. Behav Res Ther. 1978;16(5):363–9.PubMedCrossRef
3.
go back to reference Jeffery R, Drewnowski A, Epstein L. Long-term maintenance of weight loss. Health Psychol. 2000;19(1 Suppl):5–16.PubMedCrossRef Jeffery R, Drewnowski A, Epstein L. Long-term maintenance of weight loss. Health Psychol. 2000;19(1 Suppl):5–16.PubMedCrossRef
4.
go back to reference NIH. (United States Department of Health and Human Services). NIH Guide: Findings of Scientific Misconduct. 2001 December 13, 2001. NIH. (United States Department of Health and Human Services). NIH Guide: Findings of Scientific Misconduct. 2001 December 13, 2001.
5.
go back to reference Heshka S, Anderson J, Atkinson R, et al. Weight loss with self-help compared with a structured commercial program: a randomized trial. J Am Med Assoc. 2003;2003(289):14. Heshka S, Anderson J, Atkinson R, et al. Weight loss with self-help compared with a structured commercial program: a randomized trial. J Am Med Assoc. 2003;2003(289):14.
6.
go back to reference Loewenstein G, Brennan T, Volpp KG. Asymmetric paternalism to improve health behaviors. J Am Med Assoc. 2007;298(20):2415–7.CrossRef Loewenstein G, Brennan T, Volpp KG. Asymmetric paternalism to improve health behaviors. J Am Med Assoc. 2007;298(20):2415–7.CrossRef
7.
go back to reference Volpp K, John L, Troxel AB, Norton L, Fassbender J, Loewenstein G. Financial incentive-based approaches for weight loss: a randomized trial. J Am Med Assoc. 2008;300(22):2631–7.CrossRef Volpp K, John L, Troxel AB, Norton L, Fassbender J, Loewenstein G. Financial incentive-based approaches for weight loss: a randomized trial. J Am Med Assoc. 2008;300(22):2631–7.CrossRef
8.
go back to reference Kahneman D, Tversky A. Prospect theory: an analysis of decision making under risk. Econometrica. 1979;47:263–91.CrossRef Kahneman D, Tversky A. Prospect theory: an analysis of decision making under risk. Econometrica. 1979;47:263–91.CrossRef
9.
go back to reference Ryan D, Espeland M, Foster G, et al. Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control Clin Trials. 2003;24(5):610–28.PubMedCrossRef Ryan D, Espeland M, Foster G, et al. Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control Clin Trials. 2003;24(5):610–28.PubMedCrossRef
10.
go back to reference Ariely D, Wertenbroch K. Procrastination, deadlines, and performance: self-control by precommitment. Psychol Sci. 2002;13(3):219–24.PubMedCrossRef Ariely D, Wertenbroch K. Procrastination, deadlines, and performance: self-control by precommitment. Psychol Sci. 2002;13(3):219–24.PubMedCrossRef
11.
go back to reference Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403.PubMedCrossRef Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403.PubMedCrossRef
12.
go back to reference Svenson O, Fischhoff B, MacGregor D. Perceived driving safety and seatbelt usage. Accident Analysis & Prevention. 1985;17(2):119-133. Svenson O, Fischhoff B, MacGregor D. Perceived driving safety and seatbelt usage. Accident Analysis & Prevention. 1985;17(2):119-133.
13.
go back to reference Weinstein ND. Unrealistic optimism about susceptibility to health problems: Conclusions from a community-wide sample Journal of Behavioral Medicine. 1987;10(5):1573-3521. Weinstein ND. Unrealistic optimism about susceptibility to health problems: Conclusions from a community-wide sample Journal of Behavioral Medicine. 1987;10(5):1573-3521.
14.
go back to reference Tversky A, Kahneman D. Loss aversion in riskless choice: a reference-dependent model. Q J Econ. 1991;106(4):1039–61.CrossRef Tversky A, Kahneman D. Loss aversion in riskless choice: a reference-dependent model. Q J Econ. 1991;106(4):1039–61.CrossRef
15.
go back to reference Ainslie G. Specious reward: a behavioral theory of impulsiveness and impulse control. Psychol Bull. 1975;82:463–96.PubMedCrossRef Ainslie G. Specious reward: a behavioral theory of impulsiveness and impulse control. Psychol Bull. 1975;82:463–96.PubMedCrossRef
16.
go back to reference Thaler RH. Some empirical evidence on time inconsistency. Rev Econ Stud. 1981;23:165–80. Thaler RH. Some empirical evidence on time inconsistency. Rev Econ Stud. 1981;23:165–80.
17.
go back to reference Loewenstein G, Prelec D. Anomalies in intertemporal choice: evidence and an interpretation. Q J Econ. 1992;107:573–97.CrossRef Loewenstein G, Prelec D. Anomalies in intertemporal choice: evidence and an interpretation. Q J Econ. 1992;107:573–97.CrossRef
18.
go back to reference Kirby K. Bidding on the future: evidence against normative discounting of delayed rewards. J Exp Psychol Gen. 1997;126:54–70.CrossRef Kirby K. Bidding on the future: evidence against normative discounting of delayed rewards. J Exp Psychol Gen. 1997;126:54–70.CrossRef
19.
go back to reference Griffin D, Buehler R. Frequency, probability, and prediction: easy solutions to cognitive illusions? Cogn Psychol. 1999;38:48–78.PubMedCrossRef Griffin D, Buehler R. Frequency, probability, and prediction: easy solutions to cognitive illusions? Cogn Psychol. 1999;38:48–78.PubMedCrossRef
20.
go back to reference Locke EA, Latham GP.A theory of goal setting and task performance Englewood Cliffs. NJ: Prentice Hall; 1990. Locke EA, Latham GP.A theory of goal setting and task performance Englewood Cliffs. NJ: Prentice Hall; 1990.
Metadata
Title
Financial Incentives for Extended Weight Loss: A Randomized, Controlled Trial
Authors
Leslie K. John, MS
George Loewenstein, PhD
Andrea B. Troxel, ScD
Laurie Norton, MA
Jennifer E. Fassbender, MS
Kevin G. Volpp, MD, PhD
Publication date
01-06-2011
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 6/2011
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-010-1628-y

Other articles of this Issue 6/2011

Journal of General Internal Medicine 6/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.